Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea · Delayed Price · Currency is KRW 27,050
-400 (-1.46%)
At close: Aug 13, 2026
Aimed Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 38,596 | 5,023 | -3,304 | -9,023 | -6,168 |
Depreciation & Amortization | 1,608 | 1,382 | 1,464 | 1,058 | 780.45 |
Loss (Gain) From Sale of Assets | 20.3 | 16.22 | -0.66 | 7.24 | 12.95 |
Loss (Gain) From Sale of Investments | 1,227 | 317.63 | -96.75 | 1,084 | 716.25 |
Stock-Based Compensation | 1,869 | 1,315 | 667.74 | 1,061 | 1,015 |
Other Operating Activities | -17,673 | 12,254 | 3,753 | 1,518 | -87.96 |
Change in Accounts Receivable | -15,196 | -3,300 | -6,922 | 45.46 | -38.64 |
Change in Unearned Revenue | -540.96 | -454.55 | -499.72 | 1,154 | 140.79 |
Change in Other Net Operating Assets | 867.6 | 1,308 | 64.83 | 450.07 | -278.35 |
Operating Cash Flow | 10,777 | 17,860 | -4,874 | -2,644 | -3,908 |
Operating Cash Flow Growth | 947.67% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -1,164 | -353.69 | -223.73 | -795.7 | -451.6 |
Sale of Property, Plant & Equipment | - | - | 23.14 | - | 0.63 |
Cash Acquisitions | - | - | - | - | -0.04 |
Sale (Purchase) of Intangibles | -24.47 | -8.94 | -1,456 | - | -69.8 |
Investment in Securities | -108,142 | -33,390 | -14,412 | -13,472 | 5,888 |
Other Investing Activities | -114.38 | -182.03 | -319.85 | -232.63 | -276.82 |
Investing Cash Flow | -109,445 | -33,935 | -16,389 | -14,500 | 5,090 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Long-Term Debt Repaid | - | -538.39 | -475.11 | -454.13 | -257.1 |
Net Debt Issued (Repaid) | -674.72 | -538.39 | -475.11 | -454.13 | -257.1 |
Issuance of Common Stock | 69,165 | 76,066 | - | 5,220 | 161.66 |
Other Financing Activities | -0 | - | - | 76.8 | 71.83 |
Financing Cash Flow | 68,490 | 118,462 | 24,270 | 15,734 | -23.61 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | 594.29 | -467.7 | 18.76 | 0.61 | 5.23 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | 0 | - |
Net Cash Flow | -29,583 | 101,920 | 3,026 | -1,410 | 1,163 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 9,614 | 17,506 | -5,098 | -3,440 | -4,360 |
Free Cash Flow Growth | 1155.67% | - | - | - | - |
Free Cash Flow Margin | 14.39% | 37.03% | -43.35% | -2009.11% | -3924.65% |
Free Cash Flow Per Share | 146.64 | 352.83 | -143.49 | -100.72 | -130.42 |
Levered Free Cash Flow | -867.23 | 10,316 | -2,704 | -520.51 | - |
Unlevered Free Cash Flow | -780.28 | 10,351 | -2,646 | -446.09 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 132.41 | 51.71 | 87.55 | 118.44 | 122.89 |
Cash Income Tax Paid | 4,771 | 3,295 | 130.5 | -5.47 | 13.28 |
Change in Working Capital | -14,870 | -2,447 | -7,357 | 1,650 | -176.2 |